VPN Plus+ ExclusiveThe Diet Trial is a Diagnostic TestAugust 25, 2022Meagan Painter, DVM, DACVD, addresses how to understand the elimination diet trial as a diagnostic test when approaching the allergic patient. Specifics will include a review of the food allergy phenotype, best practices for diet selection, strategies for improving owner compliance, and a current review of the literature. A strong focus will be placed on introducing practical solutions that help general practitioners improve the diagnostic outcome after a diet trial is prescribed. Numerous case studies will be presented to highlight these concepts.
SPONSORED CONTENTThe Case for Year-Round Heartworm Prevention and Affordable OptionsVeterinarians are often more than just clinicians - they’re advisors, educators, and, increasingly, financial counselors. In today’s economy, pet owners may hesitate to invest in year-round prevention due to budget constraints; but, skipping even a few months of heartworm protection can have serious consequences. + Learn More
Abaxis gains USDA approval of VetScan FLEX4 Rapid TestJanuary 23, 2018Abaxis Inc., a diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, announced that the USDA, Center for Veterinary Biologics, approved its new VetScan FLEX4 Rapid Test for veterinary use. The FLEX4 is a 4-in-1 lateral flow test used for detecting heartworm antigen as well as antibodies for Lyme, Ehrlichia, and Anaplasma in canine whole blood, serum, or plasma samples. The VetScan FLEX4 Rapid Test offers improved shelf life, ease of use, room temperature storage, and price, as well as a 4-in-1 alternative for vector-borne disease testing on a single cassette, according to the company. Results are available within 8 to 10 minutes. The company plans to ship the FLEX4 to its distributors later this quarter; it should be available to U.S. veterinarians shortly thereafter. Abaxis said it will continue to sell the single test platform currently available for heartworm disease, Lyme disease, Ehrlichiosis, and anaplasmosis.
Phoenix Lab to offer Giardia Vet Chek from TechLabJanuary 12, 2018TechLab Inc., a developer and manufacturer of rapid noninvasive diagnostic tests for gastrointestinal diseases, announced that Phoenix Lab will be one of the first veterinary reference labs in the Pacific Northwest to offer Giardia Vet Chek test to customers. "For more than 28 years, Phoenix Lab's mission has been to bring the best science and best service to our veterinary community in the Pacific Northwest region," said Faye Sturtevant, DVM, Ph.D. and CEO at Phoenix Lab. "We are excited to add TechLab to our menu of clinical veterinary testing, which aligns with our vision to partner with best-in-class companies as we expand nationally." The Giardia Vet Chek test is an automatable enzyme immunoassay optimized for canine and feline fecal samples to aid in the diagnosis of giardiasis. The test is the first TechLab product to be manufactured under the company's USDA establishment license.
Zoetis launches witness Lepto IgM-based diagnostic testApril 14, 2017Zoetis’ new Witness Lepto is a rapid, point-of-care diagnostic test available in the U.S. that detects the primary immune response to canine leptospires as early as four days after infection, according to the company.
